Massively Increasing the number of Antibody-Virus Interactions across Studies
A central challenge in every field of biology is to use existing measurements
to predict the outcomes of future experiments. In this work, we consider the
wealth of antibody inhibition data against variants of the influenza virus. Due
to this virus's genetic diversity and evolvability, the variants examined in
one study will often have little-to-no overlap with other studies, making it
difficult to discern common patterns or unify datasets for further analysis. To
that end, we develop a computational framework that predicts how an antibody or
serum would inhibit any variant from any other study. We use this framework to
greatly expand 7 influenza datasets utilizing hemagglutination inhibition,
validating our method upon 200,000 existing measurements and predicting more
than 2,000,000 new values along with their prediction uncertainties. This
data-driven approach does not require any information beyond each virus's name
and measurements, and even datasets with as few as 5 viruses can be expanded,
making this approach widely applicable. Future influenza studies using
hemagglutination inhibition can directly utilize our curated datasets to
predict newly measured antibody responses against ~80 H3N2 influenza viruses
from 1968-2011, whereas immunological studies utilizing other viruses or a
different assay only need to find a single partially-overlapping dataset to
extend their work. In essence, this approach enables a shift in perspective
when analyzing data from "what you see is what you get" into "what anyone sees
is what everyone gets."